TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32919527 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32919527 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32919527 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 32919527 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 32919861 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 32920226 — Predictive Biomarker (PRD): MBTPS2 mRNA
Genes: MBTPS2; S2P
Study 32920723 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 32922577 — Surrogate Endpoint (SUR): Blood pressure
Study 32923144 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32923156 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 32923849 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 32923853 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 32923921 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32924986 — Predictive Biomarker (PRD): MCM5 mRNA
Genes: MCM5; CDC46
Study 32925563 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 32926343 — Surrogate Endpoint (SUR): Blood pressure
Study 32926395 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 32926395 — Predictive Biomarker (PRD): ABCC3 mRNA
Genes: ABCC3; CMOAT2; MLP2; MRP3
Study 32926574 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32926574 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32926574 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32928136 — Predictive Biomarker (PRD): CDCA7L mRNA
Genes: CDCA7L; HR1; JPO2; R1
Study 32928264 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study 32928795 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 32928796 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 32928796 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 32928858 — Monitoring Biomarker (MOI): HBV DNA
Study 32929049 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32929477 — Surrogate Endpoint (SUR): Bone mineral density
Study 32929483 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study 32930023 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 32930325 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study 32930807 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 32930969 — Surrogate Endpoint (SUR): Serum creatinine
Study 32931556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32933874 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 32934722 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 32934758 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32935170 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 32935170 — Surrogate Endpoint (SUR): Bone mineral density
Study 32935287 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32936949 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32938232 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study 32938232 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32939030 — Predictive Biomarker (PRD): LAMP3 mRNA
Genes: LAMP3; DCLAMP; TSC403
Study 32939030 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study 32939046 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 32939046 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32939319 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32943410 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32945596 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 32945596 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32945631 — Surrogate Endpoint (SUR): Bone mineral density
Study 32945968 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32945968 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32946850 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32947434 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32948202 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 32948202 — Predictive Biomarker (PRD): MUC4 mRNA
Genes: MUC4
Study 32948202 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32949123 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32949150 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32949150 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32949176 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 32949176 — Predictive Biomarker (PRD): TACC3 mRNA
Genes: TACC3; ERIC1
Study 32950058 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 32950058 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 32950448 — Surrogate Endpoint (SUR): Blood pressure
Study 32950749 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study 32950849 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 32951151 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32954622 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 32955176 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32955488 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 32956380 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32956407 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 32956453 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 32956651 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 32956651 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study 32956651 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32956651 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32958357 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32958357 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32958357 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32958451 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32958488 — Surrogate Endpoint (SUR): Blood pressure
Study 32959922 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32960976 — Surrogate Endpoint (SUR): Blood pressure
Study 32961393 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study 32962417 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 32962746 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study 32964020 — Surrogate Endpoint (SUR): Blood pressure
Study 32964020 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32964203 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32964203 — Surrogate Endpoint (SUR): Serum uric acid
Study 32964203 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32964317 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32965227 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 32965548 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32965659 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 32966279 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study 32966308 — Surrogate Endpoint (SUR): Blood pressure
Study 32967009 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32967807 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 32967856 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32967856 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32968425 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 32968710 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32968710 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32968710 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32969710 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32969724 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 32972320 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32972320 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32972570 — Predictive Biomarker (PRD): TCFL5 mRNA
Genes: TCFL5; CHA; E2BP1
Study 32973880 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32973950 — Surrogate Endpoint (SUR): Blood pressure
Study 32973950 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32973950 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32974034 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32975059 — Surrogate Endpoint (SUR): Blood pressure
Study 32975632 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 32975869 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 32976514 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32978195 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 32978206 — Surrogate Endpoint (SUR): Blood pressure
Study 32980364 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32982210 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32982387 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 32982393 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32982393 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 32983160 — Predictive Biomarker (PRD): TNK1 mRNA
Genes: TNK1
Study 32983965 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32983965 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study 32983965 — Predictive Biomarker (PRD): ULK1 mRNA
Genes: ULK1; KIAA0722
Study 32983965 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study 32983965 — Predictive Biomarker (PRD): FADD mRNA
Genes: FADD; MORT1; GIG3
Study 32988240 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32988996 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32989425 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32989495 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 32989612 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 32990945 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32991114 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32992048 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32993521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32993772 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study 32993794 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32994225 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study 32994273 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 32996096 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 32997124 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32997124 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32997657 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32997689 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32997689 — Monitoring Biomarker (MOI): Procalcitonin
Study 32998751 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 32998963 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 32998963 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32998965 — Predictive Biomarker (PRD): CLEC4D mRNA
Genes: CLEC4D; CLECSF8; MCL
Study 32999466 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33000389 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33000470 — Surrogate Endpoint (SUR): Blood pressure
Study 33001310 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 33001967 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33003107 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33003107 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 33004046 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 33004133 — Surrogate Endpoint (SUR): Blood pressure
Study 33004541 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33004542 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33004542 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33004691 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 33004691 — Predictive Biomarker (PRD): IGFBP1 mRNA
Genes: IGFBP1; IBP1
Study 33004691 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 33004905 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33006086 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33006109 — Predictive Biomarker (PRD): NBN mRNA
Genes: NBN; NBS; NBS1; P95
Study 33006109 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 33006749 — Surrogate Endpoint (SUR): Blood pressure
Study 33008401 — Surrogate Endpoint (SUR): Blood pressure
Study 33009222 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 33010231 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33010459 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33011075 — Predictive Biomarker (PRD): ABCB5 mRNA
Genes: ABCB5
Study 33011075 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33012343 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33012782 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33015525 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study 33016100 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33020594 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 33021872 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33022004 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33022066 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33022852 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33022852 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33022852 — Predictive Biomarker (PRD): Hormone receptor
Study 33023763 — Surrogate Endpoint (SUR): Blood pressure
Study 33023948 — Predictive Biomarker (PRD): FANCD2 mRNA
Genes: FANCD2; FACD
Study 33024987 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33024987 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 33025093 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33025213 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33025213 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 33025482 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33025482 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33025482 — Predictive Biomarker (PRD): Hormone receptor
Study 33026184 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33026184 — Safety Biomarker (SAF): RAS pathway
Study 33026463 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33026772 — Predictive Biomarker (PRD): WWTR1 mRNA
Genes: WWTR1; TAZ
Study 33026965 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33027067 — Surrogate Endpoint (SUR): Blood pressure
Study 33027186 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33028098 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 33028346 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33029116 — Safety Biomarker (SAF): BDNF
Study 33029743 — Surrogate Endpoint (SUR): Blood pressure
Study 33030848 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33030975 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study 33030975 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 33031542 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33032489 — Surrogate Endpoint (SUR): Blood pressure
Study 33032541 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33032541 — Surrogate Endpoint (SUR): Blood pressure
Study 33032662 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33032662 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 33033101 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33033800 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 33033800 — Surrogate Endpoint (SUR): Blood pressure
Study 33034050 — Predictive Biomarker (PRD): CRYM mRNA
Genes: CRYM; THBP
Study 33034194 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study 33034806 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 33034839 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 33034839 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33035333 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33035333 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 33037105 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33037135 — Predictive Biomarker (PRD): CDH17 mRNA
Genes: CDH17
Study 33037135 — Predictive Biomarker (PRD): TNFRSF10B mRNA
Genes: TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; UNQ160/PRO186
Study 33038344 — Predictive Biomarker (PRD): LEPR mRNA
Genes: LEPR; DB; OBR
Study 33039599 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33039599 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33040013 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33040420 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 33040720 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33041107 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33041987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study 33043304 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 33043304 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 33043735 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study 33044494 — Surrogate Endpoint (SUR): Blood pressure
Study 33044566 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33045316 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 33045994 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 33046516 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33046516 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 33046518 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33046517 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study 33046573 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 33046621 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 33046621 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study 33046621 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 33046621 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33046765 — Surrogate Endpoint (SUR): Blood pressure
Study 33046870 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33046870 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 33046998 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33047329 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 33047329 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 33047329 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 33047329 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 33048203 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33048619 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 33048900 — Surrogate Endpoint (SUR): Serum creatinine
Study 33050459 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33051459 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33051459 — Surrogate Endpoint (SUR): Blood pressure
Study 33052556 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33052556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1